Genoskin launches new website

September 2016. After several months of hard work and dedication, we are thrilled to officially announce the launch of our new website! We invite you to visit us at www.genoskin.com We have built our new website with you in mind. The streamlined user interface provides a more interactive experience, allowing our colleagues, partners, clients and prospects to easily find the information

Read more


Genoskin is a winner of the 7th edition of the NETVA contest: See you soon in Boston !

The NETVA (New Technology Venture Accelerator) program consists in a preparation and exposure to high-tech US markets for young innovative French companies. It is run by the Office for Science & Technology of the Embassy of France in the United States in three locations: Boston, San Francisco and Washington, DC. Each year, 15 French startups are selected though a national competition

Read more


Genoskin Happy New Year Wishes 2016


Genoskin presents new skin cancer model at Meet2Win

Genoskin launches new OncoSkin® skin cancer model at Meet2Win Genoskin has developed a new skin cancer model for the in vitro study of melanoma. Patients who suffer from this highly dangerous type of skin cancer currently have limited therapeutic options when the cancer reaches metastasis. The OncoSkin® skin cancer model now enables in vitro studies on live melanoma spheroids implanted

Read more


Genoskin attends 2014 meeting European Society for Dermatological Research

44th annual ESDR meeting, Copenhagen, Denmark     Genoskin will attend the 44th annual European Society for Dermatological Research meeting in Copenhagen, Denmark. The congress will take place from September 10 to September 13, 2014. The European Society for Dermatological Research (ESDR) aims to disseminate knowledge and facilitate exchange of information relevant to investigative dermatology between clinicians and scientists worldwide.
Read more

Genoskin attended the 9th World Congress on Alternatives and Animal use in Life Sciences

Genoskin attended the 9th World Congress On Alternatives and Animal Use in The Life Sciences  (WC9 2014) organized in Prague, Czech Republic, from the 24 to the 28 August. “The world congress provides an exceptional forum to underline the importance of both the ethical issues of animal experimentation and the approach to the life sciences in the 21st century.”